CCND1 and breast carcinoma: The miR-17/20-mediated inhibition of breast cancer cellular proliferation via cyclin D1 repression, together with the finding that miR-17/20 inhibits breast cancer cell invasiveness (42), is consistent with a model in which miR-17/20 is a negative growth regulator in breast cancer cells.